Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2019-04-18 2019-04-18
Drug Identification Number 02471353 02471353
Brand name RIVA-OLMESARTAN RIVA-OLMESARTAN
Common or Proper name Riva-olmesartan 20mg Riva-olmesartan 20mg
Company Name LABORATOIRE RIVA INC. LABORATOIRE RIVA INC.
Ingredients OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 & 100 30 & 100
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date 2019-04-17 2019-04-17
Actual discontinuation date 2019-04-17 2019-04-17
Remaining supply date 2019-04-17 2019-04-17
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments